These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 23807641)

  • 21. EGF/EGFR axis contributes to the progression of cholangiocarcinoma through the induction of an epithelial-mesenchymal transition.
    Clapéron A; Mergey M; Nguyen Ho-Bouldoires TH; Vignjevic D; Wendum D; Chrétien Y; Merabtene F; Frazao A; Paradis V; Housset C; Guedj N; Fouassier L
    J Hepatol; 2014 Aug; 61(2):325-32. PubMed ID: 24704591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hedgehog signaling between cancer cells and hepatic stellate cells in promoting cholangiocarcinoma.
    Kim Y; Kim MO; Shin JS; Park SH; Kim SB; Kim J; Park SC; Han CJ; Ryu JK; Yoon YB; Kim YT
    Ann Surg Oncol; 2014 Aug; 21(8):2684-98. PubMed ID: 24682719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aberrant expression of alpha-fetoprotein in intrahepatic cholangiocarcinoma: an exceptional occurrence.
    Vij K; Wang HL
    Int J Surg Pathol; 2008 Apr; 16(2):194-8. PubMed ID: 18417680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative changes in tumor-associated M2 macrophages characterize cholangiocarcinoma and their association with metastasis.
    Thanee M; Loilome W; Techasen A; Namwat N; Boonmars T; Pairojkul C; Yongvanit P
    Asian Pac J Cancer Prev; 2015; 16(7):3043-50. PubMed ID: 25854403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of ECM1 contributes to migration and invasion in cholangiocarcinoma cell.
    Xiong GP; Zhang JX; Gu SP; Wu YB; Liu JF
    Neoplasma; 2012; 59(4):409-15. PubMed ID: 22489696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification.
    Akiba J; Nakashima O; Hattori S; Tanikawa K; Takenaka M; Nakayama M; Kondo R; Nomura Y; Koura K; Ueda K; Sanada S; Naito Y; Yamaguchi R; Yano H
    Am J Surg Pathol; 2013 Apr; 37(4):496-505. PubMed ID: 23388123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regarding: epithelial-mesenchymal transition induced by hepatitis C virus core protein in cholangiocarcinoma.
    Balsano C; Conti B; Arciello M
    Ann Surg Oncol; 2011 Mar; 18(3):896; author reply 897. PubMed ID: 20645009
    [No Abstract]   [Full Text] [Related]  

  • 28. Identification of CXCL5/ENA-78 as a factor involved in the interaction between cholangiocarcinoma cells and cancer-associated fibroblasts.
    Okabe H; Beppu T; Ueda M; Hayashi H; Ishiko T; Masuda T; Otao R; Horlad H; Mima K; Miyake K; Iwatsuki M; Baba Y; Takamori H; Jono H; Shinriki S; Ando Y; Baba H
    Int J Cancer; 2012 Nov; 131(10):2234-41. PubMed ID: 22337081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD24 expression is a prognostic factor in intrahepatic cholangiocarcinoma.
    Su MC; Hsu C; Kao HL; Jeng YM
    Cancer Lett; 2006 Apr; 235(1):34-9. PubMed ID: 16125303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of Smad7 in cholangiocarcinoma: prognostic significance and implications for tumor metastasis.
    Huang Q; Liu L; Liu CH; Shao F; Xie F; Zhang CH; Hu SY
    Asian Pac J Cancer Prev; 2012; 13(10):5161-5. PubMed ID: 23244128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ALCAM is a Novel Cytoplasmic Membrane Protein in TNF-α Stimulated Invasive Cholangiocarcinoma Cells.
    Adisakwattana P; Suwandittakul N; Petmitr S; Wongkham S; Sangvanich P; Reamtong O
    Asian Pac J Cancer Prev; 2015; 16(9):3849-56. PubMed ID: 25987048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methionine aminopeptidase 2 over-expressed in cholangiocarcinoma: potential for drug target.
    Sawanyawisuth K; Wongkham C; Pairojkul C; Saeseow OT; Riggins GJ; Araki N; Wongkham S
    Acta Oncol; 2007; 46(3):378-85. PubMed ID: 17450475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conjugated bile acids promote cholangiocarcinoma cell invasive growth through activation of sphingosine 1-phosphate receptor 2.
    Liu R; Zhao R; Zhou X; Liang X; Campbell DJ; Zhang X; Zhang L; Shi R; Wang G; Pandak WM; Sirica AE; Hylemon PB; Zhou H
    Hepatology; 2014 Sep; 60(3):908-18. PubMed ID: 24700501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic bile duct injury associated with fibrotic matrix microenvironment provokes cholangiocarcinoma in p53-deficient mice.
    Farazi PA; Zeisberg M; Glickman J; Zhang Y; Kalluri R; DePinho RA
    Cancer Res; 2006 Jul; 66(13):6622-7. PubMed ID: 16818635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of Wnt signaling induces cell apoptosis and suppresses cell proliferation in cholangiocarcinoma cells.
    Zhang KS; Zhou Q; Wang YF; Liang LJ
    Oncol Rep; 2013 Sep; 30(3):1430-8. PubMed ID: 23799613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epithelial-mesenchymal transition induced by hepatitis C virus core protein in cholangiocarcinoma.
    Li T; Li D; Cheng L; Wu H; Gao Z; Liu Z; Jiang W; Gao YH; Tian F; Zhao L; Wang S
    Ann Surg Oncol; 2010 Jul; 17(7):1937-44. PubMed ID: 20162464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The expression of HSP27 is associated with poor clinical outcome in intrahepatic cholangiocarcinoma.
    Romani AA; Crafa P; Desenzani S; Graiani G; Lagrasta C; Sianesi M; Soliani P; Borghetti AF
    BMC Cancer; 2007 Dec; 7():232. PubMed ID: 18154639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intrahepatic cholangiocarcinoma arising in chronic advanced liver disease and the cholangiocarcinomatous component of hepatocellular cholangiocarcinoma share common phenotypes and cholangiocarcinogenesis.
    Xu J; Sasaki M; Harada K; Sato Y; Ikeda H; Kim JH; Yu E; Nakanuma Y
    Histopathology; 2011 Dec; 59(6):1090-9. PubMed ID: 22175889
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peribiliary Glands as the Cellular Origin of Biliary Tract Cancer.
    Nakagawa H; Hayata Y; Yamada T; Kawamura S; Suzuki N; Koike K
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29895797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two distinct pathways of carcinogenesis in primary sclerosing cholangitis.
    Zen Y; Quaglia A; Heaton N; Rela M; Portmann B
    Histopathology; 2011 Dec; 59(6):1100-10. PubMed ID: 22175890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.